HLA DR13 and HCV vertical infection

Area of Science:

• Immunogenetics
• Virology
• Hepatology

Background:

• Vertical transmission of hepatitis C virus (HCV) remains a concern.
• Maternal Human Immunodeficiency Virus (HIV) coinfection is a known risk factor, but other factors are less understood.
• Immunogenetic factors, specifically Human Leukocyte Antigen (HLA) profiles, may influence HCV transmission.

Purpose of the Study:

• To investigate the association between maternal and neonatal HLA profiles and the risk of vertical HCV transmission.
• To explore the potential protective role of specific HLA antigens against HCV acquisition in infants.

Main Methods:

• HLA typing was performed on 18 infants with vertically transmitted HCV and 17 serum-reverted infants.
• HLA typing was also conducted on 20 mothers of these infants.
• Logistic regression analysis was used to assess the association between HLA antigens and HCV transmission risk.

Main Results:

• Infants possessing the HLA-DR13 antigen showed a significantly reduced risk of vertical HCV transmission (p < 0.01).
• This protective association with HLA-DR13 persisted even when maternal HIV coinfection was considered, with both factors showing independent effects.
• Breast-feeding and maternal HLA profiles were not found to significantly impact vertical HCV transmission risk.

Conclusions:

• The study identifies a significant protective association between infant HLA-DR13 and reduced vertical HCV transmission.
• HLA-DR13 may play a role in modulating the immune response, enhancing viral clearance and preventing HCV infection in infants.
• These findings contribute to understanding HCV pathogenesis and identifying infants at higher risk, aiding in prevention strategy development.